[HTML][HTML] Identification of Novel Vaccine Candidates against Multidrug-Resistant Acinetobacter baumannii

DG Moriel, SA Beatson, DJ Wurpel, J Lipman… - PloS one, 2013 - journals.plos.org
Acinetobacter baumannii is an emerging opportunistic bacterium associated with
nosocomial infections in intensive care units. The alarming increase in infections caused by …

[HTML][HTML] Delineating the Plausible Molecular Vaccine Candidates and Drug Targets of Multidrug-Resistant Acinetobacter baumannii

S Mujawar, R Mishra, S Pawar, D Gatherer… - Frontiers in cellular and …, 2019 - frontiersin.org
Nosocomial infections have become alarming with the increase of multidrug-resistant
bacterial strains of Acinetobacter baumannii. Being the causative agent in~ 80% of the …

[HTML][HTML] Recent Advances in the Pursuit of an Effective Acinetobacter baumannii Vaccine

PS Gellings, AA Wilkins, LA Morici - Pathogens, 2020 - mdpi.com
Acinetobacter baumannii has been a major cause of nosocomial infections for decades. The
absence of an available vaccine coupled with emerging multidrug resistance has prevented …

[HTML][HTML] Mapping Global Prevalence of Acinetobacter baumannii and Recent Vaccine Development to Tackle It

C Ma, S McClean - Vaccines, 2021 - mdpi.com
Acinetobacter baumannii is a leading cause of nosocomial infections that severely threaten
public health. The formidable adaptability and resistance of this opportunistic pathogen have …

Current advances and challenges in the development of Acinetobacter vaccines

W Chen - Human vaccines & immunotherapeutics, 2015 - Taylor & Francis
Acinetobacter baumannii is a major cause of healthcare-associated infections worldwide
with high morbidity and mortality. The clinical treatment of A. baumannii infections has …

[HTML][HTML] The Prevalence of Multidrug-Resistant Acinetobacter baumannii and Its Vaccination Status among Healthcare Providers

A Elbehiry, E Marzouk, I Moussa, Y Mushayt… - Vaccines, 2023 - mdpi.com
There is growing concern among healthcare providers worldwide regarding the prevalence
of multidrug-resistant Acinetobacter baumannii (A. baumannii). Some of the worst hospital …

[HTML][HTML] Promising Acinetobacter baumannii Vaccine Candidates and Drug Targets in Recent Years

YC Tan, C Lahiri - Frontiers in Immunology, 2022 - frontiersin.org
In parallel to the uncontrolled use of antibiotics, the emergence of multidrug-resistant
bacteria, like Acinetobacter baumannii, has posed a severe threat. A. baumannii …

Identification of novel vaccine candidates against Acinetobacter baumannii using reverse vaccinology

MH Chiang, WC Sung, SP Lien, YZ Chen… - Human vaccines & …, 2015 - Taylor & Francis
Acinetobacter baumannii (Ab) is a global emerging bacterium causing nosocomial infections
such as pneumonia, meningitis, bacteremia and soft tissue infections especially in intensive …

Facing the challenges of multidrug-resistant Acinetobacter baumannii: progress and prospects in the vaccine development

NA Mat Rahim, HY Lee, U Strych… - Human Vaccines & …, 2021 - Taylor & Francis
ABSTRACT In 2017, the World Health Organization (WHO) named A. baumannii as one of
the three antibiotic-resistant bacterial species on its list of global priority pathogens in dire …

[HTML][HTML] Vaccines for Acinetobacter baumannii: thinking “out of the box”

F Perez, RA Bonomo - Vaccine, 2014 - ncbi.nlm.nih.gov
We are indeed fortunate that modern medicine continues to offer advancements that
promise better and longer lives. Delivering on that promise depends on our ability to …